VentriPoint Diagnostics Ltd. (CVE:VPT) shares were down 7.4% during mid-day trading on Wednesday . The stock traded as low as C$0.12 and last traded at C$0.13. Approximately 270,069 shares were traded during trading, an increase of 21% from the average daily volume of 222,974 shares. The stock had previously closed at C$0.14.
The stock has a market cap of $8.36 million and a PE ratio of -2.64.
In related news, Director George Adams sold 1,500,000 shares of the company’s stock in a transaction dated Thursday, January 17th. The stock was sold at an average price of C$0.16, for a total transaction of C$232,500.00. Following the transaction, the director now directly owns 65,999 shares of the company’s stock, valued at approximately C$10,229.85.
WARNING: This news story was originally posted by Fairfield Current and is owned by of Fairfield Current. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.fairfieldcurrent.com/news/2019/04/17/ventripoint-diagnostics-vpt-trading-down-7-4.html.
VentriPoint Diagnostics Company Profile (CVE:VPT)
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers.
Featured Story: Purposes and Functions of the Federal Reserve
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.